Pluristem Therapeutics Inc. (NASDAQ:PSTI) shares rose 8.
In a research note released yesterday, Canaccord analyst Mark Massaro reiterated a Buy rating on OraSure Technologies (NASDAQ:OSUR) shares, and a $11 price target following investor meetings. Massaro commented: …
In a research note published today, Canaccord analyst Mark Massaro reiterated coverage with a “Buy” rating on OraSure Technologies (OSUR) and a price target of $11.00 as OSUR now expects to be …
In a research note issued today, Canaccord analyst Mark Massaro reiterated a Buy rating and boosted his price target on OraSure Technologies (OSUR) to $11.00 …